Literature DB >> 15899657

How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?

Lone G M Jørgensen1, Lisbeth Fredholm, Per Hyltoft Petersen, Henrik Hey, Pia Munkholm, Ivan Brandslund.   

Abstract

Clinical activity indices are essential instruments in monitoring inflammatory bowel diseases such as Crohn's disease (CD) and ulcerative colitis (UC). To subclassify components of disease indices in CD and UC, investigate technical noise in estimation of the indices, establish a signal-to-noise ratio (SNR), evaluate correlation between indices and calculate the reference change value (RCV) for selected biochemical variables in individual cases, 50 patients with CD and 49 patients with UC were included in the study. Qualitative index variables were assessed for scoring errors. The standard deviation (SD) was estimated according to a rectangular model, while SD in biochemical variable scoring was estimated according to a Gaussian model; a combined SD was also calculated. These values were investigated for their individual contribution to variation. The 95% CI of an index value was based on +/- 1.96 x SD(combined) and a change in separate biochemical variables was calculated as RCV 1.96 x radical2 x SD(combined). Correlation between different disease activity indices was assessed for unexplained variation. The Crohn's disease activity index (CDAI) had the highest variation compared to the van Hees (Hees) and the Harvey-Bradshaw index (HBI) in CD, but it also had the best SNR, whereas HBI had the lowest. In UC the clinical activity index (CAI) showed the highest variance, but the best SNR compared to Seo's activity index (AI). The 95% CI of the CDAI discriminatory activity sum of 150 in individual cases was 105-195, whereas the 95% interval for a change was +/-62.4. Self-reported wellness contributed 40% to total variance in the CDAI. Factors of clinical importance increased errors in estimates and variance of the indices. Poor correlation was obtained between activity indices, with up to 70% unexplained variance. The SD(combined) for estimated errors was as high as 23 points, with the best SNR being approximately 20. Index factors increase the sensitivity of SNRs to errors and lower the disease specificity. Sensitivity optimisation may be achieved by standardisation of the variables and their use.

Entities:  

Mesh:

Year:  2005        PMID: 15899657     DOI: 10.1515/CCLM.2005.073

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  19 in total

1.  Medical management of Crohn's disease.

Authors:  Paul A Feldman; Daniel Wolfson; Jamie S Barkin
Journal:  Clin Colon Rectal Surg       Date:  2007-11

2.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

Review 3.  Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.

Authors:  A Cholapranee; G S Hazlewood; G G Kaplan; L Peyrin-Biroulet; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-03-22       Impact factor: 8.171

4.  Current and Emerging Approaches to the Diagnosis and Treatment of Crohn's Disease Strictures.

Authors:  Briton Lee; Bari Dane; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-04

5.  Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.

Authors:  Ferenc Nagy; Tamas Molnar; Zoltan Szepes; Klaudia Farkas; Tibor Nyari; Janos Lonovics
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

6.  Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Panagiotis Georgoulias; Chara Tzavara; Varvara Valotassiou; Anastasia Kapsoritaki; Spyros P Potamianos
Journal:  BMC Gastroenterol       Date:  2010-10-14       Impact factor: 3.067

Review 7.  Expanding role of capsule endoscopy in inflammatory bowel disease.

Authors:  Blair-S Lewis
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 8.  Contrast-enhanced Ultrasound for Detection of Crohn's Disease Activity: Systematic Review and Meta-analysis.

Authors:  Zbigniew Serafin; Marcin Białecki; Agnieszka Białecka; Luca Maria Sconfienza; Maria Kłopocka
Journal:  J Crohns Colitis       Date:  2015-10-27       Impact factor: 9.071

9.  A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

Authors:  Mark Lamet
Journal:  Dig Dis Sci       Date:  2010-07-30       Impact factor: 3.199

10.  Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.

Authors:  Catherine Emerson; Matthew Fuller-Tyszkiewicz; Rebecca Orr; Kimina Lyall; Lauren Beswick; Lisa Olive; David Skvarc; Robert A Cummins; Antonina Mikocka-Walus
Journal:  Dig Dis Sci       Date:  2021-05-29       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.